The global Medical Ventilator market size will be USD 1952.2 million in 2024.

According to Cognitive Market Research, the global Medical Ventilator market size will be USD 1952.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.50% from 2024 to 2031.North America held the major market share for more than 40% of the global revenue with a market size of USD 780.8 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.Europe accounted for a market share of over 30% of the global revenue with a market size of USD 585.66 million.Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 449.0 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.Latin America had a market share of more than 5% of the global revenue with a market size of USD 97.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 39.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.The Critical Care Ventilators category is the fastest growing segment of the Medical Ventilator industry  Market Dynamics of Medical Ventilator MarketKey Drivers for Medical Ventilator MarketIncreasing Prevalence of Chronic Respiratory Diseases to Boost Market GrowthThe growing prevalence of chronic respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and bronchitis, has significantly increased the demand for medical ventilators. As of 2022, 4.6% of adults have been diagnosed with COPD, emphysema, or chronic bronchitis. Chronic lower respiratory diseases, including asthma, caused 147,382 deaths, with a mortality rate of 44.2 per 100,000 people. In 2019, the Global Burden of Disease (GBD) estimated 21.6 million Disability-Adjusted Life Years (DALYs) were attributed to asthma, making it the 34th leading cause of global disease burden and responsible for a fifth of all DALYs from chronic respiratory diseases. Additionally, the World Health Organization (WHO) identifies COPD as a leading cause of death globally, with rising respiratory infections like pneumonia and influenza further emphasizing the need for ventilator support. As populations age and become more vulnerable to these conditions, the demand for ventilators is expected to increase.Increasing Geriatric Population Prone to Respiratory Disorders to Drive Market GrowthThe elderly population is more susceptible to various health issues, particularly respiratory disorders, as aging increases the likelihood of developing these conditions. Individuals aged 65 and older are at higher risk due to a decline in quality of life and self-efficacy. By 2030, 1 in 6 people globally will be aged 60 or older, with the population in this age group growing from 1 billion in 2020 to 1.4 billion. By 2050, the global population of people aged 60 and above is expected to double to 2.1 billion, and the number of individuals aged 80 or older will triple to 426 million. In 2020, the population of those 60 years and older surpassed the number of children under 5. Between 2015 and 2050, the proportion of the world’s population over 60 will nearly double, rising from 12% to 22%. As a result, more elderly patients with various ailments are increasingly seeking intensive care unit (ICU) treatment, including the use of ventilators.Restraint Factor for the Medical Ventilator MarketHigh Costs of Ventilators and Side Effects Associated with the Usage of Ventilators Will Limit Market GrowthOne of the major obstacles to the growth of the medical ventilator market is the high cost of ventilators and related equipment. Advanced ventilators, especially those featuring non-invasive ventilation, artificial intelligence (AI) integration, and real-time monitoring, are often expensive. In low-income countries or regions with constrained healthcare budgets, the high cost of these devices makes it challenging for hospitals to acquire the necessary equipment. Additionally, ventilators require specialized technicians for maintenance and repairs, further adding to the financial strain. Ventilators are also associated with significant risks that affect patient health, which is dampening market demand. One of the most common and serious risks for ventilated patients is pneumonia. The breathing...

根据认知市场研究，全球医疗呼吸机市场规模预计在2024年将达到19.52亿美元。从2024年至2031年，其复合年增长率（CAGR）将达到9.50%。北美市场占据了全球收入的超过40%份额，在2024年的市场规模达到7.808亿美元，并将在2024年至2031年间以7.7%的复合年增长率增长。欧洲在全球收入中占据了超过30%的市场份额，市场规模为5.8566亿美元。亚太地区在全球收入中占据了大约23%的市场份额，在2024年的市场规模为4.49亿美元，并将在2024年至2031年间以11.5%的复合年增长率增长。拉丁美洲在全球收入中占据了超过5%的市场份额，在2024年的市场规模为9761万美元，并将在2024年至2031年间以8.9%的复合年增长率增长。中东和非洲在全球收入中占据了大约2%的市场份额，预计2024年的市场规模为3904万美元，并将在2024年至2031年间以9.2%的复合年增长率增长。重症监护呼吸机类别是医疗呼吸机行业中增长最快的部分。医疗呼吸机市场的市场动态医疗呼吸机市场的关键驱动因素慢性呼吸系统疾病（如慢性阻塞性肺疾病（COPD）、哮喘和支气管炎）的发病率上升将推动市场增长。截至2022年，4.6%的成年人已被诊断患有COPD、肺气肿或慢性支气管炎。包括哮喘在内的慢性下呼吸系统疾病导致了147,382人死亡，死亡率为每10万人44.2人。2019年，全球疾病负担（GBD）估计，有2160万失能调整生命年（DALYs）归因于哮喘，使其成为全球疾病负担的第34大原因，并占所有慢性呼吸系统疾病DALYs的五分之一。此外，世界卫生组织（WHO）将COPD确定为全球死亡的主要原因，不断上升的呼吸道感染，如肺炎和流感，进一步强调了呼吸机支持的需求。随着人口老龄化，对这些条件更加脆弱，预计对呼吸机的需求将增加。易受呼吸道疾病影响的老年人口增加将推动市场增长。随着年龄的增长，老年人更容易患上各种健康问题，尤其是呼吸道疾病。65岁及以上的人由于生活质量和工作效率的下降而面临更高的风险。到2030年，全球将有六分之一的人年龄在60岁或以上，这个年龄组的人口将从2020年的10亿增长到14亿。到2050年，全球60岁及以上的人口预计将翻一番，达到21亿，而80岁及以上的人口数量将增加三倍，达到4.26亿。2020年，60岁及以上的人口数量超过了5岁以下的儿童数量。在2015年至2050年期间，世界60岁以上人口的比例将几乎翻倍，从12%上升到22%。因此，越来越多的患有各种疾病的老年患者正在寻求重症监护室（ICU）治疗，包括使用呼吸机。医疗呼吸机市场的限制因素呼吸机和与其使用相关的副作用的高成本将限制市场增长。医疗呼吸机市场增长的主要障碍之一是呼吸机和相关设备的成本高昂。先进的呼吸机，特别是那些具有无创通气、人工智能（AI）集成和实时监控功能的呼吸机，通常价格昂贵。在低收入国家或医疗保健预算受限的地区，这些设备的成本高使得医院难以获得必要的设备。此外，呼吸机需要专业的技术人员进行维护和修理，这进一步增加了经济压力。呼吸机还与影响患者健康的重大风险相关，这抑制了市场需求。呼吸患者最常见的严重风险之一是肺炎。